Characterization of erythromycin resistance in Campylobacter coli and Campylobacter jejuni isolated from pig offal in New Zealand

Journal of Applied Microbiology

Volumn 97, Issue 1, 2004, Pages 141-148

  Harrow, S A ^a,d   Gilpin, B J ^b   Klena, J D ^a,c  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b ESR Christchurch Science Centre   (New Zealand)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d New Zealand Institute of Plant and Food Research   (New Zealand)

Author keywords

23S rDNA; Campylobacter; Erythromycin resistance; New Zealand; Pigs

Indexed keywords

ANTIBIOTICS; ELECTROPHORESIS; ESCHERICHIA COLI; GENE ENCODING; MAMMALS;

23S RIBOSOMAL DNA; ANTIMICROBIAL RESISTANCES; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CAMPYLOBACTERS; ERYTHROMYCIN RESISTANCE; NALIDIXIC ACID; NEW ZEALAND; PIG; RIBOSOMAL DNA;

ANTIMICROBIAL AGENTS;

CIPROFLOXACIN; ERYTHROMYCIN; NALIDIXIC ACID; RIBOSOME DNA; TETRACYCLINE;

BACTERIUM;

ANTIBIOTIC RESISTANCE; ARTICLE; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; CONTROLLED STUDY; DNA FINGERPRINTING; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NEW ZEALAND; NONHUMAN; NUCLEOTIDE SEQUENCE; PULSED FIELD GEL ELECTROPHORESIS; SWINE;

BACTERIA (MICROORGANISMS); CAMPYLOBACTER; CAMPYLOBACTER COLI; CAMPYLOBACTER JEJUNI; ESCHERICHIA COLI; SUS SCROFA;

EID: 3042822395     PISSN: 13645072     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2004.02278.x     Document Type: Article

References (31)

1. Aarestrup, F.M., Nielsen, E.M., Madsen, M. and Engberg, J. (1997) Antimicrobial susceptibility patterns of thermophilic Campylobacter spp. from humans, pigs, cattle, and broilers in Denmark. Antimicrobial Agents and Chemotherapy 41, 2244-2250.
2. Agricultural Compounds and Veterinary Medicines Group (2000) Review of Animal Health Antibiotic Products and their Potential for Contributing to the Development of Antibiotic Resistant Strains of Human Bacterial Pathogens. pp. 1-74. Food Assurance Authority, Ministry of Agriculture and Forestry. Available from http:// www.nzfsa.govt.nz/acvm/subject/antibiotic-resistance/index.htm.
3. Aquino, M.H.C., Filgueiras, A.L.L., Ferreira, M.C.S., Oliveira, S.S., Bastos, M.C. and Tibana, A. (2002) Antimicrobial resistance and plasmid profiles of Campylobacter jejuni and Campylobacter coli from human and animal sources. Letters in Applied Microbiology 34, 149-153.
4. Douthwaite, S. (1992) Functional interactions within 23S rRNA involving the peptidyltransferase center. Journal of Bacteriology 174, 1333-1338.
5. Dowling, J., MacCulloch, D. and Morris, A.J. (1998) Antimicrobial susceptibility of Campylobacter and Yersinia enterocolitica isolates. New Zealand Medical Journal 111, 281.
6. Engberg, J., Aarestrup, F.M., Taylor, D.E., Gerner-Smidt, P. and Nachamkin, I. (2001) Quinolone and macrolide resistance in Campylobacter jejuni and Campylobacter coli: resistance mechanisms and trends in human isolates. Emerging Infectious Diseases 7, 24-34.
7. Fernández, H., Mansilla, M. and González, V. (2000) Antimicrobial susceptibility of Campylobacter jejuni subsp. jejuni assessed by E-test and double dilution agar method in Southern Chile. Memórias do Instituto Oswaldo Cruz 95, 247-249.
8. Gaudreau, C. and Gilbert, H. (1998) Antimicrobial resistance of clinical strains of Campylobacter jejuni subsp. jejuni isolated from 1985 to 1997 in Quebec, Canada. Antimicrobial Agents and Chemotherapy 42, 2106-2108.
9. Goodchild, C.B.D., Riley, D. and Morris, A.J. (2001). Antimicrobial susceptibility of Campylobacter species. New Zealand Medical Journal 114, 560-561.
10. Hoge, C.W., Gambel, J.M., Srijan, A., Pitarangsi, C. and Echeverria, P. (1998) Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clinical Infectious Diseases 26, 341-345.
11. Huysmans, M.B. and Turnidge, J.D. (1997) Disc susceptibility testing for thermophilic Campylobacters. Pathology 29, 209-216.
12. Jensen, L.B. and Aarestrup, F.M. (2001) Macrolide resistance in Campylobacter coli of animal origin in Denmark. Antimicrobial Agents and Chemotherapy 45, 371-372.
13. Mamelli, L., Amoros, J., Pagès, J. and Bolla, J. (2003) A phenylalanine-arginine β-naphthylamide sensitive multidrug efflux pump involved in intrinsic and acquired resistance of Campylobacter to macrolides. International Journal of Antimicrobial Agents 22, 237-241.
14. Meadows, G. (2000) Index of Veterinary Specialities. Medimedia (NZ) Ltd. pp. 57-121. Auckland: Johnston Press.
15. Mixter, P., Klena, J.D., Flom, G.A., Siegesmund, A.M. and Konkel, M.E. (2003) In vivo tracking of Campylobacter jejuni using a novel recombinant expressing green fluorescent protein. Applied and Environmental Microbiology 69, 2864-2874.
16. NCCLS (1997) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard Document M7-A4, 4th edn. Wayne, PA: National Committee for Clinical Laboratory Standards.
17. NCCLS (1999) Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard Document M2-A7, 7th edn. Wayne, PA: National Committee for Clinical Laboratory Standards.
18. Niwa, H., Huma, T., Okamoto, K. and Itoh, K. (2001) Rapid detection of mutations associated with resistance to erythromycin in Campylobacter jejuni/coli by PCR and line probe assay. International Journal of Antimicrobial Agents 18, 359-364.
19. Pitcher, D.G., Saunders, N.A. and Owen, R.J. (1989) Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Letters in Applied Microbiology 8, 151-156.
20. Roberts, M.C., Sutcliffe, J., Courvalin, P., Jensen, L.B., Rood, J. and Seppala, H. (1999) Nomenclature for macrolide and macrolide-lincosamide- streptogramin B resistance determinants. Antimicrobial Agents and Chemotherapy 43, 2823-2830.
21. Scott, W.G., Scott, H.M., Lake, R.J. and Baker, M.G. (2000) Economic cost to New Zealand of foodborne infectious disease. New Zealand Medical Journal 113, 281-284.
22. Sjögren, E., Lindblom, G.B. and Kaijser, B. (1997) Norfloxacin resistance in Campylobacter jejuni and Campylobacter coli isolates from Swedish patients. Journal of Antimicrobial Chemotherapy 40, 257-261.
23. Sneyd, E. and Baker, M. (2003) Infectious Diseases in New Zealand: 2002 Annual Surveillance Summary. pp. 1-178. Prepared as part of the Ministry of Health contract for scientific services (MoH report FW 0332) Kenepuru, ESR, May 2003. Available from http:// www.esr.cri.nz/surveillance/annual-surveillance. php.
24. Taylor, D.E. (1992) Antimicrobial resistance of Campylobacter jejuni and Campylobacter coli to tetracycline, chloramphenicol, and erythromycin. In Campylobacter jejuni: Current Status and Future Trends ed. Nachamkin, I., Blaser, M.J. and Tompkins, L. pp. 74-83. Washington, DC: American Society for Microbiology.
25. Taylor, D.E. and Courvalin, P. (1988) Mechanisms of antibiotic resistance in Campylobacter species. Antimicrobial Agents and Chemotherapy 32, 1107-1112.
26. Thompson, J.D., Gibson, T.J., Plewniak, F., Jeanmougin, F. and Higgins, D.G. (1997) The Clustal X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tool. Nucleic Acids Research 25, 4876-4882.
27. Thwaites, R.T. and Frost, J.A. (1999) Drug resistance in Campylobacter jejuni, Campylobacter coli, and Campylobacter lari isolated from humans in North West England and Wales, 1997. Journal of Clinical Pathology 52, 812-814.
28. Vester, B. and Douthwaite, S. (2001) Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrobial Agents and Chemotherapy 45, 1-12.
29. Weisblum, B. (1995) Erythromycin resistance by ribosome modification. Antimicrobial Agents and Chemotherapy 39, 577-585.
30. White, P.A., McIver, C.J., and Rawlinson, W.D. (2001) Integrons and gene cassettes in the Enterobacteriaceae. Antimicrobial Agents and Chemotherapy 45, 2658-2661.
31. Yan, W. and Taylor, D.E. (1991) Characterization of erythromycin resistance in Campylobacter jejuni and Campylobacter coli. Antimicrobial Agents and Chemotherapy 35, 1989-1996.